Hypnion
Lexington
About Hypnion
Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters. Hypnion is acquired by Eli Lilly and Company. Hypnion was founded in 2000 and is based in Worcester, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $78.0M
- Funding stage: M&A
- Last round: Series B (Dec 2005)
- Website: hypnion.com
- Phone: (781)778-0300
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Therapeutics
Canonical: https://fsome.com/organization/hypnion-490829 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.